clinical trial · NCT00546351
Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.
UCB Pharma·phase3·completed·n = 621
Painful Diabetic NeuropathyLacosamide
brief summary
SP746 (NCT00546351) is a multi-center, open-label, follow-on trial. The purpose of this trial is to assess safety and tolerability of long-term exposure of lacosamide (previously referred to as SPM 927) in subjects with painful distal diabetic neuropathy.
started
May 1, 2004
primary completion
Jan 1, 2011
completion
Jan 1, 2011
last updated
Sep 21, 2023
official title
A Multi-center, Open-label, follow-on Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy Including a Double-blind, Randomized Time Point Withdrawal Subtrial.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol